A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever

A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever
复制标题

一项关于托珠单抗治疗家族性地中海热患者疗效和安全性的随机、双盲、安慰剂对照 III 期试验

DOI:
10.55563/clinexprheumatol/fgx9vv
复制
发表时间:
2022
期刊:
Clin Exp Rheumatol.
影响因子:
--
通讯作者:
Kawakami A.
Kawakami A.
中科院分区:
--
文献类型:
--
作者:
Koga T;Sato S;Hagimori N;Yamamoto H;Ishimura M;Yasumi T;Kirino Y;Ikeda K;Yachie A;Migita K;Kishida D;Atsumi T;Kawakami A.

文献摘要

相似文献